About the Company
Perrigo Company plc, commonly referred to as Perrigo, is a private label over-the-counter pharmaceuticals manufacturing company. The company has two headquarters located in Dublin, Ireland and Allegan, USA. As of 2020, it has an employee base of over 11,100 individuals working on more than 3,000 product formulations. Other than its two headquarters, it also has an office operating in Portugal. It operates under three segments, namely Rx Pharmaceuticals, Consumer Self-Care Americas and Consumer Self-Care International.
It has stock-keeping units of more than 14,000, and it offers products under several categories, such as Nutrition, Pain and Sleep-Aids, Oral Self-Care, Healthy Lifestyle, Prescription, Skincare and Personal Hygiene, Digestive Health and Vitamins, Minerals and Supplements. Some of its products that are marketed in North America are clearlax, Advantage, mucus.DM, personal lubricant, acid reducer, aspirin, naproxen sodium, etc. Its notable European products are Panodil 500, NiOuitin, Nytol, bronchostop, Phytosun aroms, Plackers, XL.S Medical, Coldrex, etc. The company also has a subsidiary named Omega Pharma.
This company was founded in 1887 by two general store owners named Charles and Luther Perrigo as the L. Perrigo Company. By 1991, Perrigo Corporation had an initial public offering (IPO) on the NASDAQ stock exchange. However, as of 2021, Perrigo shares trade on the New York Stock Exchange (NYSE) and Tel Aviv Stock Exchange(TASE) under the ticker symbol PRGO. It is also a component of the S&P 500 index. Over the years, it has acquired several companies, and its first significant acquisition was Agis Industries Limited, a generic pharmaceuticals company, in 2005. It took over four companies in 2008; these were JB Laboratories, Unico Holdings, Galpharm International and Laboratories Diba SA. In 2010, it acquired PBM Holdings Inc. and Orion Laboratories Pty Ltd. From 2011 to 2016, Perrigo acquired seven companies in total, namely Paddock Laboratories Inc. in 2011, Sergeant’s Pet Care Products Inc. in 2012, Elan and Rosemont Pharmaceuticals Ltd in 2013, Omega Pharma in 2015 and Geiss, Destin & Dunn and Geiss, Proteon Therapeutics in 2016. The company has received several recognitions in the past few years. In 2020, OTC awarded it the title of “OTC Company of the Year”. Forbes also recognised it in its 2019 list of America’s Best Midsize Employers.;
|Organisation||Perrigo Company Public Limited Company|
|Industry||Drug Manufacturers—Specialty & Generic|